| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 570.3 | 386.4 | 496.2 | 498.9 | 541.1 |
| Age-adjusted comparative prevalence of diabetes, % | - | 4.2 | 5.0 | 5.6 | 6.0 |
| People with undiagnosed diabetes, in 1,000s | - | - | 166.3 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 33.5 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 422.3 | 812.9 | 837.7 | 924.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 5.3 | 5.4 | 5.9 | 6.3 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 389.1 | 401.1 | 422.8 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 4.8 | 5.2 | 5.2 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 2,610.0 | 11,623.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 0.9 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.4 | 0.4 | 0.8 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 1.0 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 2.7 | - | 5.0 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 9.2 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 3,761.3 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 2.1 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 293.7 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 877.7 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 3,808.5 | 3,791.8 | 3,960.2 |
| Total diabetes-related health expenditure, ID million | - | - | 3,710.9 | 3,694.7 | 3,858.7 |
| Diabetes-related health expenditure per person, USD | - | 5,442.0 | 7,674.7 | 7,641.1 | 7,980.3 |
| Diabetes-related health expenditure per person, ID | - | - | 7,478.0 | 7,445.3 | 7,775.8 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 6,341.0 | 6,763.9 | 7,259.2 | 7,407.2 | 7,822.5 |
| Population of children (0-14 y), in 1,000s | 1,648.0 | - | 1,793.8 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 2,349.4 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||